It is hypothesized that BG mitigates neuroinflammation by modulating the PI3K-Akt, MAPK, and other inflammatory pathways via rare saponins, such as ginsenoside F1, thereby contributing to the treatment of depression. Here, AKT1 is linked to depressive symptom measurement.